e-learning
resources
Virtual 2021
07.09.2021
Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
PREVALENCE OF NON TUBERCULOUS MYCOBACTERIA (NTM) IN HIGH RISK COPD PATIENTS
B. Gonzalez Quero (Barakaldo, Spain), E. Tabernero Huguet (Barakaldo, Spain), P. Sobradillo Ecenarro (Barakaldo, Spain), E. Garay Llorente (Barakaldo, Spain), J. Andia Iturrate (Barakaldo, Spain), L. Garcia Echebarria (Barakaldo, Spain), M. Iriberri Pascual (Barakaldo, Spain)
Source:
Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Session:
Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Session type:
E-poster
Number:
3093
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Gonzalez Quero (Barakaldo, Spain), E. Tabernero Huguet (Barakaldo, Spain), P. Sobradillo Ecenarro (Barakaldo, Spain), E. Garay Llorente (Barakaldo, Spain), J. Andia Iturrate (Barakaldo, Spain), L. Garcia Echebarria (Barakaldo, Spain), M. Iriberri Pascual (Barakaldo, Spain). PREVALENCE OF NON TUBERCULOUS MYCOBACTERIA (NTM) IN HIGH RISK COPD PATIENTS. 3093
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
SALBUTAMOL AND IPRATROPIUM BROMIDE ARE HIGH RISK FACTORS FOR ATRIAL ARRHYTHMIAS IN PATIENTS WITH COPD AND CVS DISEASES.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
COMPARISON OF PHYSICAL PERFORMANCE AND SPIROMETRY VALUES ACCORDING TO FALL RISK OF COPD SUBJECTS
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020
FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP)
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018
BACTERIAL IMMUNOTHERAPY IN COPD AND/OR BRONCHIECTASIS FREQUENT EXACERBATOR PATIENTS. A RETROSPECTIVE STUDY.
Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD
Year: 2018
IMPROVING HOME OXIGEN THERAPY IN PATIENTS WITH INTERSTITIAL LUNG DISEASES (ILDs): APPLICATION OF A PORTABLE NON-INVASIVE VENTILATION (NIV) DEVICE
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
GLN27GLU POLYMORPHISM IN THE ß2-ADRENERGIC RECEPTOR GENE AND THE RISK OF ARTERIAL HYPERTENSION IN PATIENTS WITH BRONCHIAL ASTHMA
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018
USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
RISK FACTORS FOR LONG-TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
IMMUNOLOGICAL EVENTS AND SURVIVAL IN LUNG CANCER PATIENTS WITH COPD
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
TREATMENT OF MDR-TB PATIENTS WITH DELETION POLYMORPHISM OF XENOBIOTICS DETOXICATION SYSTEM GENES OF GLUTATHIONE-S-TRANSFERASE
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019
MAINTAINING PULMONARY REHABILITATION EFFECTS IN COPD PATIENTS AT HOME – A PROTOCOL STUDY
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Year: 2020
NEBULIZER AEROSOL DRUG DELIVERY THROUGH HIGH FLOW NASAL CANNULA IN ADULT PATIENTS
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
EXTRARESPIRATORY SYMPTOM BURDEN IN PATIENTS HOSPITALIZED FOR A COPD EXACERBATION: IT’S NOT ONLY ABOUT RESPIRATORY SYMPTOMS
Source: International Congress 2019 – Innovations in care for chronic respiratory conditions
Year: 2019
INCREASED MYOSTATIN AS A NEGATIVE REGULATOR OF MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: CLINICAL IMPLICATIONS
Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation
Year: 2020
LIPID PEROXIDATION IN PATIENTS WITH COPD AND CHRONIC HEART FAILURE.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
HEALTH RELATED QUALITY OF LIFE (HRQoL) AMONG PATIENTS WITH NON CYSTIC FIBROSIS BROCHIECTASIS (BE) IN STABLE PHASE
Source: International Congress 2018 – Management of bronchiectasis and large airway diseases
Year: 2018
RISK FACTORS FOR THE DEVELOPMENT OF SARCOPENIA IN PATIENTS WITH COVID-19
Source: Virtual Congress 2021 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2021
RATES OF LUNG FUNCTION DECLINE DIFFERS BETWEEN COPD PHENOTYPES
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept